133 related articles for article (PubMed ID: 10374322)
1. [Relationship between p16 and Rb protein expression in astrocytomas].
Lin Y; Huang C; Liu D
Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):340-2. PubMed ID: 10374322
[TBL] [Abstract][Full Text] [Related]
2. Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.
Puduvalli VK; Kyritsis AP; Hess KR; Bondy ML; Fuller GN; Kouraklis GP; Levin VA; Bruner JM
Int J Oncol; 2000 Nov; 17(5):963-9. PubMed ID: 11029499
[TBL] [Abstract][Full Text] [Related]
3. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
[TBL] [Abstract][Full Text] [Related]
5. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
Hara A; Saegusa M; Ichinoe M; Okayasu I
J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
[TBL] [Abstract][Full Text] [Related]
7. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival.
Hilton DA; Penney M; Evans B; Sanders H; Love S
Am J Surg Pathol; 2002 Apr; 26(4):472-8. PubMed ID: 11914625
[TBL] [Abstract][Full Text] [Related]
9. [The expression of plasminogen activator inhibitor-1 (PAI-1) gene in human astrocytomas].
Bu X; Zhang X; Cao W
Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):433-5. PubMed ID: 11244954
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Polycomb-Group protein BMI1 and correlation with p16 in astrocytomas an immunohistochemical study on 80 cases.
Tirabosco R; De Maglio G; Skrap M; Falconieri G; Pizzolitto S
Pathol Res Pract; 2008; 204(9):625-31. PubMed ID: 18450386
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas.
Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Saito T; Matsuura S; Yamasaki F; Arita K; Kurisu K
J Neurooncol; 2006 May; 77(3):273-7. PubMed ID: 16614947
[TBL] [Abstract][Full Text] [Related]
13. [The expression of Rb, p16 and cyclin D1 in 41 esophageal cancers].
Zheng J; Zhou C; Xiao F
Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):336-9. PubMed ID: 9388858
[TBL] [Abstract][Full Text] [Related]
14. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P
Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
[TBL] [Abstract][Full Text] [Related]
15. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
Ghazizadeh M; Jin E; Shimizu H; Fujiwara M; Arai S; Ohaki Y; Takemura T; Kawanami O
Respiration; 2005; 72(1):68-73. PubMed ID: 15753637
[TBL] [Abstract][Full Text] [Related]
16. CDKN2A promoter hypermethylation in astrocytomas is associated with age and sex.
Alves MK; Faria MH; Neves Filho EH; Ferrasi AC; Pardini MI; de Moraes Filho MO; Rabenhorst SH
Int J Surg; 2013; 11(7):549-53. PubMed ID: 23721661
[TBL] [Abstract][Full Text] [Related]
17. [The expression of P16, Rb and cyclin D1 and biological behavior of laryngeal cancer].
Dai S; Huang W; Gan X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):299-301. PubMed ID: 10743098
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity in human astrocytomas: spatial distribution of P16 and TP53 deletions in biopsies.
Steilen-Gimbel H; Steudel WI; Feiden W; Moringlane JR; Henn W; Zang KD
Cancer Genet Cytogenet; 1999 Sep; 113(2):115-9. PubMed ID: 10484976
[TBL] [Abstract][Full Text] [Related]
19. [Expression of p53, c-erbB1, c-myc and p16 gene proteins in human glioma].
Zhu R; Kang S; Wu D
Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):343-5. PubMed ID: 10374323
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
